POST-ARTEMISININ DELAYED HEMOLYSIS AFTER TREATMENT OF MALARIA
INTRODUCTION: Falciparum malaria is highly endemic in sub-Saharan Africa. The disease is caused by the intra-cellular parasite Plasmodium within erythrocytes. The recommended treatment is artemisinin-based combination which is efficient and safe. In some patients, artemisinin can cause hemolysis weeks after treatment, presenting with severe anemia. Most of the published cases were following intravenous treatment. We present a case of a falciparum malaria patient with hemolysis and severe anemia two weeks after oral treatment with artemisinin-based combination therapy.
Medienart: |
Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:162 |
---|---|
Enthalten in: |
Harefuah - 162(2023), 3 vom: 01. März, Seite 143-145 |
Sprache: |
Hebräisch |
---|
Beteiligte Personen: |
Baharav, Nadav [VerfasserIn] |
---|
Themen: |
9RMU91N5K2 |
---|
Anmerkungen: |
Date Completed 28.03.2023 Date Revised 28.03.2023 published: Print Citation Status MEDLINE |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
NLM354714465 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM354714465 | ||
003 | DE-627 | ||
005 | 20231226062818.0 | ||
007 | tu | ||
008 | 231226s2023 xx ||||| 00| ||heb c | ||
028 | 5 | 2 | |a pubmed24n1182.xml |
035 | |a (DE-627)NLM354714465 | ||
035 | |a (NLM)36966369 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a heb | ||
100 | 1 | |a Baharav, Nadav |e verfasserin |4 aut | |
245 | 1 | 0 | |a POST-ARTEMISININ DELAYED HEMOLYSIS AFTER TREATMENT OF MALARIA |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
500 | |a Date Completed 28.03.2023 | ||
500 | |a Date Revised 28.03.2023 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a INTRODUCTION: Falciparum malaria is highly endemic in sub-Saharan Africa. The disease is caused by the intra-cellular parasite Plasmodium within erythrocytes. The recommended treatment is artemisinin-based combination which is efficient and safe. In some patients, artemisinin can cause hemolysis weeks after treatment, presenting with severe anemia. Most of the published cases were following intravenous treatment. We present a case of a falciparum malaria patient with hemolysis and severe anemia two weeks after oral treatment with artemisinin-based combination therapy | ||
650 | 4 | |a Case Reports | |
650 | 4 | |a English Abstract | |
650 | 4 | |a Journal Article | |
650 | 7 | |a Antimalarials |2 NLM | |
650 | 7 | |a artemisinin |2 NLM | |
650 | 7 | |a 9RMU91N5K2 |2 NLM | |
650 | 7 | |a Artemisinins |2 NLM | |
700 | 1 | |a Schwartz, Eli |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Harefuah |d 1946 |g 162(2023), 3 vom: 01. März, Seite 143-145 |w (DE-627)NLM000070491 |x 0017-7768 |7 nnns |
773 | 1 | 8 | |g volume:162 |g year:2023 |g number:3 |g day:01 |g month:03 |g pages:143-145 |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 162 |j 2023 |e 3 |b 01 |c 03 |h 143-145 |